Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resonance Health Ltd (AU:RHT)
ASX:RHT
RESEARCH TOOLSreports
Holding AU:RHT?
Track your performance easily
RHT Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.04 - AU$0.09
Previous CloseAU$0.06
Volume2.40K
Average Volume (3M)344.04K
Market Cap
AU$26.66M
Enterprise ValueAU$20.14M
Total Cash (Recent Filing)AU$6.78M
Total Debt (Recent Filing)AU$268.22K
Price to Earnings (P/E)145.0
Beta0.87
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares OutstandingN/A
10 Day Avg. Volume744,140
30 Day Avg. Volume344,044
Standard Deviation0.19
R-Squared0.11
Alpha-0.00452
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)5.78
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Resonance Health Ltd News
PremiumCompany Announcements
Resonance Health Secures Major Clinical Trial Contract
PremiumCompany Announcements
Resonance Health Trading Halt Ahead of Major Announcement
PremiumCompany Announcements
Resonance Health Director Alters Shareholding Structure
PremiumCompany Announcements
Resonance Health Ltd Updates on Securities Conversion
PremiumCompany Announcements
Resonance Health Issues New Equity Securities
PremiumCompany Announcements
Resonance Health Announces Cessation of SecuritiesPremiumCompany Announcements
Resonance Health Reports Strong Growth and Expansion
PremiumCompany Announcements
Resonance Health Announces Significant TurnaroundOptions Prices
Currently, No data available
---
Ownership Overview
RHT FAQ
What was Resonance Health Ltd’s price range in the past 12 months?
Resonance Health Ltd lowest share price was AU$0.04 and its highest was AU$0.09 in the past 12 months.
What is Resonance Health Ltd’s market cap?
Currently, no data Available
When is Resonance Health Ltd’s upcoming earnings report date?
Resonance Health Ltd’s upcoming earnings report date is Mar 04, 2025 which is in 99 days.
How were Resonance Health Ltd’s earnings last quarter?
Resonance Health Ltd released its earnings results on Aug 29, 2024. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.002.
Is Resonance Health Ltd overvalued?
According to Wall Street analysts Resonance Health Ltd’s price is currently Overvalued.
Does Resonance Health Ltd pay dividends?
Resonance Health Ltd does not currently pay dividends.
What is Resonance Health Ltd’s EPS estimate?
Resonance Health Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Resonance Health Ltd have?
Resonance Health Ltd has 459,616,150 shares outstanding.
What happened to Resonance Health Ltd’s price movement after its last earnings report?
Resonance Health Ltd reported an EPS of AU$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 20%.
Which hedge fund is a major shareholder of Resonance Health Ltd?
Currently, no hedge funds are holding shares in AU:RHT
---
Resonance Health Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:RHT Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.33%
12-Months-Change
Fundamentals
Return on Equity
1.62%
Trailing 12-Months
Asset Growth
84.67%
Trailing 12-Months
Company Description
Resonance Health Ltd
Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver and HepaFat-Scan. The company's operating segment includes Services; Research and Development and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of revenue North America and Europe-Middle-East-Africa (EMEA) and also has a presence in Asia/Pacific.
---
Technical Analysis
---